The Therapeutic role of Magnesium in different depressive syndromes of the male population comprising of different age groups

The basic and fundamental role of Mg as being the second most abundant intercellular cation is established in various studies. It is identified as a divalent metal cofactor in over 300 enzymatic reactions involving energy metabolism and protein and nucleic acid synthesis. The biological function is identified in neuromuscular excitability. Mg ion regulates calcium ion flow in neuronal channels, helping to regulate neuronal Nitric Oxide production ¹ . Mg deficiency causes NMDA coupled Calcium channels to be biased towards opening, causing neuronal injury & neurological dysfunction, which may appear to humans as major depression. The present study confirms a reduction in the symptoms of depression found in the male population comprising of different age group by Mg treatment. CSF Mg has been found low in treatment resistant suicidal depression. Brain Mg is also low in TRD using phosphorous nuclear magnetic resonance Spectroscopy². A 2009 randomized clinical trial shows that Mg therapy was an effective as TCAs in depressed diabetics. Increase in brain Mg enhances both short term synaptic facilitation and long term potentiation and improves learning and memory function³. The present study is based on findings that male subjects diagnosed as depressed showed a marked reduction in behavioral and somatic features of the disease after administration of Magnesium supplement. Physiological and somatic anxiety was also alleviated in a certain age group which displayed recovery from Insomnia and agitation. Suicidal tendency was also negative in all age groups. This study focuses on the behavioral and somatic responses pertaining to brain biochemical changes induced by Magnesium therapy.